Companies: 10,795·Total market cap: $144.5T
Pharvaris N.V.

Pharvaris N.V.

PHVSNASDAQHealthcare● Active
$31.54
+$0.45(+1.45%)
Market Cap$2.2B
P/E Ratio
52W High$33.33
52W Low$15.91

Pharvaris N.V. (PHVS) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

phvs · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 12 Wall Street analysts in the past 3 months

SellBuy

Buy

12 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
11
Hold
1
Sell
0
Strong Sell
0
Total: 12 · Buy rate: 91.7%

12-Month Price Target

High

$74.00

Consensus

$56.00

+77.0% upside

Low

$42.00

Median: $52 · Last Close: $31.63

The Pharvaris N.V. (PHVS) analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month PHVS price target is $56.00, representing +77.0% upside from the current price of $31.63.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $56 (77.0%)

Consensus Target

$56.00

77.0% upside

High Target

$74

134.0%

Low Target

$42

32.8%

Current Price

$31.63

as of today

Based on analyst price targets, the PHVS stock price prediction for the next 12 months ranges from $42 to $74. The consensus PHVS price forecast of $56.00 implies 77.0% upside from the current price of $31.63.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$32.031.25%

1-day model range: $31.84–$32.21. Peak: $32.21 (+1.25%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$38+21.4%
2028$43+36.9%
2029$47+47.4%
2030$49+54.2%
2031+58.5%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)66.0Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · PHVS · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$30.69BUY
MA 10$30.19BUY
MA 20$30.23BUY
MA 50$29.35BUY
MA 100$28.10BUY
MA 200$26.08BUY
Current $PHVS · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$30.93BUY
EMA 10$30.50BUY
EMA 20$30.16BUY
EMA 50$29.35BUY
EMA 100$28.16BUY
EMA 200$26.17BUY
Current $PHVS · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citizens2026-05-13
Maintains
Market OutperformMarket Outperform
Wedbush2026-04-07
Maintains
OutperformOutperform
RBC Capital2026-04-06
Maintains
OutperformOutperform
HC Wainwright & Co.2026-03-03
Maintains
BuyBuy
Guggenheim2025-12-04
Maintains
BuyBuy
Morgan Stanley2025-12-04
Maintains
OverweightOverweight
Oppenheimer2025-12-04
Maintains
OutperformOutperform
B of A Securities2025-12-04
Maintains
NeutralNeutral
HC Wainwright & Co.2025-12-03
Maintains
BuyBuy
Morgan Stanley2025-11-14
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Pharvaris N.V. (PHVS) stock. Of the recent 31 rating actions, 1 were upgrades and 0 were downgrades. 12 analysts currently cover PHVS.

Analyst Recommendation Trends

Buy ratings01↑ +1
Hold ratings101
Sell ratings00

PHVS analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1M

↓ 99.1% YoY

Revenue Next Year

$41M

↑ 2960.6% YoY

EPS This Year

$-2.66

EPS Next Year

$-2.37

↓ 11.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast PHVS EPS of $-2.66 for the current fiscal year, based on estimates from 9 analysts. The PHVS revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The PHVS stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PHVS price target is $56.00 (+77.0% upside), with an analyst consensus of Buy.

The PHVS short-term stock prediction for tomorrow is $32.03 (+1.25%). The PHVS stock price prediction for 2027 estimates an average of $38. The PHVS stock prediction for 2030 projects a range of $46–$52.

Pharvaris N.V. trades on NASDAQ under the ticker PHVS. The PHVS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 92% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

PHVS forecast · 8 questions

According to 12 Wall Street analysts, the average 12-month PHVS price target is $56.00, with a high forecast of $74.00 and a low of $42.00. The median price target is shown in the chart above when available. This implies +77.0% potential upside from the current price of $31.63.

PHVS price targetWhat is PHVS price targetPHVS analyst price targetPHVS 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.